Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes
A strategy of intensive glucose control, involving gliclazide (modified release) and other drugs as required, that lowered the glycated hemoglobin value to 6.5% yielded a 10% re...